30 June 2025 | Monday | News
Image Source | Public Domain
Avio Health, a deep-tech company dedicated to advancing healthcare through data analytics and machine learning, today announced the launch of the world's first Functional Medicine-based Large Language Model (LLM) developed exclusively for Emagene.Life. This breakthrough follows 18 months of intensive research and development, delivering a new standard in personalized healthcare.
Through sophisticated machine learning, Avio Health's system rapidly analyzes and unifies patient blood biomarker data from around the globe. Clinicians can now go from manually interpreting labs for hours to receiving comprehensive analysis in just minutes. Emagene Life professionals report the platform significantly enhances patient care and preventive health focus, giving doctors, dieticians, and nutritionists more time to spend on meaningful interactions with patients.
"Avio Health's mission is to harness technology to streamline medical workflows while elevating patient-centric care," said Elvin Siew, Founder Avio Health.
"By partnering with Emagene Life, we've shown how Functional Medicine can be powered by advanced data analysis—ultimately delivering quicker, more precise insights that empower healthcare providers and their patients."
Key Highlights
"As pioneers in functional medicine and preventative health, we are thrilled to integrate Avio Health's advanced system," added Dr Shirley Koeg, Medical Director Emagene Life.
"This tool not only saves clinicians significant time but also allows us to tailor medical advice more effectively—enhancing the overall patient experience."
By accelerating lab analysis and boosting personalized recommendations, Avio Health and Emagene Life aim to redefine Functional Medicine in clinical practice.
Most Read
Bio Jobs
News
Editor Picks